Volume 62, Issue 11 pp. 2011-2014
Brief Report

Ovary preservation in the treatment of childhood Meigs syndrome

Michael A. Fremed BA

Corresponding Author

Michael A. Fremed BA

Albert Einstein College of Medicine, Bronx, New York

Correspondence to: Michael A. Fremed, Ullman 813, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461. E-mail: [email protected]

Search for more papers by this author
Terry L. Levin MD

Terry L. Levin MD

Department of Radiology, Division of Pediatric Radiology, Montefiore Medical Center, Bronx, New York

Search for more papers by this author
Katherine Y. Sun MD, PhD

Katherine Y. Sun MD, PhD

Department of Pathology, Montefiore Medical Center, Bronx, New York

Search for more papers by this author
Daniel A. Weiser MD

Daniel A. Weiser MD

Departments of Pediatrics and Genetics, Albert Einstein College of Medicine, Bronx, New York

Division of Pediatric Hematology/Oncology, Children's Hospital at Montefiore, Bronx, New York

Search for more papers by this author
First published: 22 May 2015
Citations: 9
Conflict of interest: Nothing to declare.

Abstract

Meigs syndrome, the combination of benign ovarian tumor, ascites, and pleural effusion, is present in a small percentage of ovarian fibromas and is infrequently reported in children. When associated with elevated CA-125 suspicion is raised for malignancy, often prompting aggressive surgical intervention. We present a case of childhood Meigs syndrome and review the relevant literature with emphasis on ovary preservation. Out of nine identified pediatric cases, one involved ovary sparing treatment and none recurred or progressed to malignancy. Our report highlights the importance of presurgical identification of Meigs syndrome in order to curtail salpingo-oophorectomy when feasible. Pediatr Blood Cancer © 2015 Wiley Periodicals, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.